New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
06:09 EDTSGYPSynergy Pharmaceuticals to start second phase 3 clinical trial for plecanatide
Synergy Pharmaceuticals announced the start of its second pivotal phase 3 clinical trial to confirm the safety and efficacy of plecanatide, its lead uroguanylin analog and once-daily oral treatment, in adult patients with chronic idiopathic constipation, or CIC. This phase 3 trial is a randomized, double-blind clinical trial to compare a 12-week, dose-ranging regimen of plecanatide against placebo in adult patients with CIC.
News For SGYP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 3, 2015
10:16 EDTSGYPOptions with decreasing implied volatility
Subscribe for More Information
July 31, 2015
10:31 EDTSGYPOptions with decreasing implied volatility
Subscribe for More Information
July 30, 2015
10:09 EDTSGYPOptions with decreasing implied volatility
Subscribe for More Information
06:55 EDTSGYPSynergy Pharmaceuticals' second Phase 3 trial of plecanatide meets endpoints
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use